Open Access

HU-308 - a synthetic cannabinoid (CB2 agonist) studies completed


HU-308 is a synthetic cannabinoid drug that acts as a cannabinoid agonist. It is highly selective for the CB2 receptor subtype, with a selectivity of over 5000x for CB2 vs CB1.

The abbreviation "HU" stands for Hebrew University.

Science and Research